Raymond James Downgrades Edwards Lifesciences (EW) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Raymond James softens on Edwards Lifesciences (EW) as confidence in growth profile begins to fade
February 6, 2023 10:35 AM ESTRaymond James downgraded Edwards Lifesciences Corp (NYSE: EW) to a Market Perform rating (From Outperform) as confidence in the companys growth profile begins to fade. EWs revenue growth has separated it from most of its peers and has long supported a premium valuation. However, analyst Jayson Bedford is... More



